NCT06714604 2024-12-03
ADVANTAGE
Sahlgrenska University Hospital
Phase 3 Recruiting
Clinical Trials
7 trialsNCT05529940 2024-11-27
NeoFOL-R Trial (Perioperative Versus Adjuvnat FOLFIRINOX in Resectable Pancreatic Cancer)
Seoul National University Hospital
Phase 3 Recruiting
NCT01827553 2024-04-11
CONKO-007
University of Erlangen-Nürnberg Medical School
Phase 3 Completed
NCT05081687 2023-10-11
BRAZIL-TNT
Hospital Israelita Albert Einstein
Phase 3 Unknown
NCT03504423 2023-01-03
Study Evaluating Efficacy and Safety of FFX Versus Combination of CPI-613 With mFFX in Patients With Metastatic Adenocarcinoma of the Pancreas
Cornerstone Pharmaceuticals
Phase 3 Completed
NCT04897854 2021-05-24
TIMEPAN
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Phase 3 Unknown
NCT01836432 2020-05-28
PILLAR
Lumos Pharma
Phase 3 Terminated